Drugs / Toujeo
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT05780151 Comparator | Jul 2023 → Jan 2025 | type 2 diabetes mellitus | Mira Zuidgeest | Completed | No outcome recorded |
| — | NCT02846233 Comparator | Aug 2016 → Dec 2018 | type 2 diabetes mellitus | University of California, San Francisco | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Toujeo | “Basal insulin (NPH, Lantus, Levimir, Toujeo or Tresiba)” NCT02846233 ↗ |